Vomiting

·MeSH: Vomiting

19 drugs in development·13 companies·2 clinical trials

Drug Pipeline by Phase

Approved(12)

Drug	Company
aponvie	HERON THERAPEUTICS, INC. /DE/ (HRTX)
aprepitant	Mylan II B.V. (MYL)
cinvanti	HERON THERAPEUTICS, INC. /DE/ (HRTX)
granisetron	Amneal Pharmaceuticals, Inc. (AMRX)
granisetron	Sana Biotechnology, Inc. (SANA)
Ondif® (licensed product)	Aquestive Therapeutics, Inc. (AQST)
palonosetron	Teva Pharmaceutical Industries Limited (TEVA)
perphenazine	Mylan II B.V. (MYL)
prochlorperazine edisylate	NEXUS BIOPHARMA INC (NEXS)
sustol	HERON THERAPEUTICS, INC. /DE/ (HRTX)
syndros	Insys Therapeutics, Inc. (INSY)
varubi	TESARO, Inc. (TSRO)

Phase 3(4)

Drug	Company
apf530	HERON THERAPEUTICS, INC. /DE/ (HRTX)
fosaprepitant	HERON THERAPEUTICS, INC. /DE/ (HRTX)
nereus	Vanda Pharmaceuticals Inc. (VNDA)
palonosetron	HERON THERAPEUTICS, INC. /DE/ (HRTX)

Preclinical(1)

Drug	Company
nt-0400	Neos Therapeutics, Inc. (NEOS)

Phase 4(2)

Drug	Company
Dexamedomedine	COGNITION THERAPEUTICS INC (CGTX)
pantoprazole	UNITED THERAPEUTICS Corp (UTHR)

BioSniper tracks 19 drugs in development for Vomiting across 13 companies.

There are 2 clinical trials targeting Vomiting tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.